CHRU de Brest Hopital Morvan

Brest 29609

1 studies enrolling now · 7 studies all time

What they study most

AML Arising From Myelodysplastic Syndrome (MDS), Anemia, Atopic Dermatitis, Cancer-associated Cachexia, Leukemia, Myeloid, Acute, Lymphoma, Non-Hodgkin, Newly Diagnosed Acute Myeloid Leukemia (AML), Non-small Cell Lung Cancer, Primary Myelofibrosis, Squamous Cell Carcinoma of the Head and Neck, Untreated AML

Studies at this site

• Visugromab in Cachexia International Trial — Recruiting now
• Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation — Running, not enrolling
• Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) — Running, not enrolling
• A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) — Stopped early
• Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis — Completed
• A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence — Completed
• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed